A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

NCT06213818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: INCB160058
DRUG: Placebo
DRUG: Esomeprazole
DRUG: Famotidine

Sponsor

Incyte Corporation